Peripheral nerve abnormalities in pediatric patients with spinal muscular atrophy
Related Experiment Video
Updated: May 23, 2026

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis
Published on: January 11, 2014
Takahiro Yonekawa1, Hirofumi Komaki, Yuko Saito
1Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Insights
Spinal muscular atrophy (SMA) subtypes I and II show distinct nerve conduction deficits. SMA I exhibits widespread motor unit loss and sensory nerve degeneration, while SMA II primarily shows leg motor deficits.
Area of Science:
- Neurology
- Neurophysiology
- Genetics
Background:
- Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder characterized by progressive muscle weakness.
- Differentiating SMA subtypes based on electrophysiological findings can aid in diagnosis and management.
Purpose of the Study:
- To identify specific nerve conduction deficits that distinguish spinal muscular atrophy (SMA) subtypes I and II.
- To compare electrophysiological parameters between SMA subtypes and age-matched controls.
Main Methods:
- Nerve conduction studies were performed on 5 SMA I patients and 10 SMA II patients.
- Parameters assessed included motor and sensory conduction velocities (MCV/SCV), compound muscle and sensory nerve action potential amplitudes (CMAP/SNAP), and F-wave occurrence (FO).
- Data were compared to age-matched healthy controls.
Main Results:
- SMA I patients showed slower MCVs, markedly decreased CMAP amplitudes, and reduced SNAP amplitudes and SCVs, indicating widespread motor unit loss and sensory nerve degeneration.
- SMA II patients exhibited significantly reduced tibial nerve CMAP amplitudes and prominent F-wave reductions in the tibial nerve, suggesting leg-specific motor unit involvement.
- SMA II patients did not show sensory nerve abnormalities.
Conclusions:
- SMA I is associated with early, widespread motor unit loss and significant sensory nerve degeneration, particularly affecting large myelinated fibers.
- SMA II presents with motor nerve deficits primarily localized to the legs in young patients, without sensory nerve involvement.
- Electrophysiological findings highlight distinct pathophysiological differences between SMA subtypes I and II.
Abstract:
We examined the specific nerve conduction deficits distinguishing spinal muscular atrophy (SMA) subtypes I and II. Five SMA I patients (age, 0.2-1.1 years) and 10 SMA II patients (age, 1.0-2.8 years) were examined. Patients were compared to age-matched controls for motor and sensory conduction velocity (MCV and SCV) changes, compound muscle and sensory nerve action potential amplitudes (CMAP and SNAP), and F-wave occurrence (FO). Slower MCVs were found in three of five SMA I patients; all five exhibited markedly decreased CMAP amplitudes. Tibial nerve CMAP amplitudes significantly reduced in SMA II patients (p<0.01). Slower SCVs and decreased SNAP amplitudes were observed in three of five SMA I patients but not in SMA II patients. Although FOs were reduced in both extremities of SMA I patients, the reduction was prominent in the tibial nerve of SMA II patients (p=0.031). Loss of motor units may be widespread in the early stage of SMA I, while specific to the legs in young SMA II patients. SMA I showed sensory nerve degeneration, especially of large myelinated fibers. SMA II showed no sensory nerve abnormalities.
Related Concept Videos
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Satellite Stem Cells and Muscular Dystrophy
Myasthenia Gravis ll: Pathophysiology

